NYSE:EW - Edwards Lifesciences Stock Price, Price Target & More

$137.09 -1.47 (-1.06 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$137.09
Today's Range$136.44 - $139.43
52-Week Range$97.63 - $143.22
Volume1.54 million shs
Average Volume1.33 million shs
Market Capitalization$29.10 billion
P/E Ratio36.08
Dividend YieldN/A
Beta0.58

About Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences logoEdwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and related delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings and the beating-heart mitral repair systems; and cardiac cannula devices, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; Oximetry Central Venous catheters, as well as clinical monitoring platforms that display a patient's physiological status; and disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

Receive EW News and Ratings via Email

Sign-up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:EW
CUSIP28176E10
Phone949-250-2500

Debt

Debt-to-Equity Ratio0.15%
Current Ratio1.80%
Quick Ratio1.41%

Price-To-Earnings

Trailing P/E Ratio36.08
Forward P/E Ratio30.26
P/E Growth2.03

Sales & Book Value

Annual Sales$3.44 billion
Price / Sales8.38
Cash Flow$4.2156 per share
Price / Cash32.52
Book Value$13.97 per share
Price / Book9.81

Profitability

EPS (Most Recent Fiscal Year)$3.80
Net Income$583.60 million
Net Margins18.11%
Return on Equity27.78%
Return on Assets15.54%

Miscellaneous

Employees12,200
Outstanding Shares210,020,000

How to Become a New Pot Stock Millionaire

Edwards Lifesciences (NYSE:EW) Frequently Asked Questions

What is Edwards Lifesciences' stock symbol?

Edwards Lifesciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences' stock split? How did Edwards Lifesciences' stock split work?

Shares of Edwards Lifesciences split on the morning of Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly minted shares were issued to shareholders after the market closes on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences stock prior to the split would have 200 shares after the split.

How will Edwards Lifesciences' stock buyback program work?

Edwards Lifesciences declared that its board has approved a share repurchase plan on Thursday, December 7th 2017, which authorizes the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

How were Edwards Lifesciences' earnings last quarter?

Edwards Lifesciences (NYSE:EW) announced its quarterly earnings data on Thursday, February, 1st. The medical research company reported $0.94 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.03. The medical research company earned $888.50 million during the quarter, compared to analyst estimates of $868.45 million. Edwards Lifesciences had a net margin of 18.11% and a return on equity of 27.78%. The business's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.75 earnings per share. View Edwards Lifesciences' Earnings History.

When is Edwards Lifesciences' next earnings date?

Edwards Lifesciences is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Edwards Lifesciences.

What guidance has Edwards Lifesciences issued on next quarter's earnings?

Edwards Lifesciences issued an update on its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $4.43-4.63 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.27. The company issued revenue guidance of $3.5-3.9 billion, compared to the consensus revenue estimate of $3.74 billion.Edwards Lifesciences also updated its Q1 guidance to $1.04-1.14 EPS.

What price target have analysts set for EW?

17 Wall Street analysts have issued twelve-month price objectives for Edwards Lifesciences' stock. Their predictions range from $115.00 to $180.00. On average, they anticipate Edwards Lifesciences' share price to reach $147.40 in the next year. View Analyst Ratings for Edwards Lifesciences.

Who are some of Edwards Lifesciences' key competitors?

Who are Edwards Lifesciences' key executives?

Edwards Lifesciences' management team includes the folowing people:
  • Mr. Michael A. Mussallem, Chairman & CEO (Age 65)
  • Mr. Scott B. Ullem, Corp. VP & CFO (Age 51)
  • Mr. Donald E. Bobo Jr., Corp. VP of Strategy & Corp. Devel. (Age 56)
  • Mr. Larry L. Wood, Corp. VP of Transcatheter Heart Valve (Age 52)
  • Ms. Catherine M. Szyman, Corp. VP of Critical Care (Age 51)

Has Edwards Lifesciences been receiving favorable news coverage?

News articles about EW stock have trended somewhat positive recently, according to Accern. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Edwards Lifesciences earned a coverage optimism score of 0.18 on Accern's scale. They also gave media headlines about the medical research company an impact score of 46.79 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Edwards Lifesciences?

Shares of EW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edwards Lifesciences' stock price today?

One share of EW stock can currently be purchased for approximately $137.09.

How big of a company is Edwards Lifesciences?

Edwards Lifesciences has a market capitalization of $29.10 billion and generates $3.44 billion in revenue each year. The medical research company earns $583.60 million in net income (profit) each year or $3.80 on an earnings per share basis. Edwards Lifesciences employs 12,200 workers across the globe.

How can I contact Edwards Lifesciences?

Edwards Lifesciences' mailing address is ONE EDWARDS WAY, IRVINE CA, 92614. The medical research company can be reached via phone at 949-250-2500 or via email at [email protected]


MarketBeat Community Rating for Edwards Lifesciences (EW)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  857 (Vote Outperform)
Underperform Votes:  627 (Vote Underperform)
Total Votes:  1,484
MarketBeat's community ratings are surveys of what our community members think about Edwards Lifesciences and other stocks. Vote "Outperform" if you believe EW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EW will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Edwards Lifesciences (NYSE:EW) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Edwards Lifesciences in the last 12 months. Their average twelve-month price target is $147.40, suggesting that the stock has a possible upside of 7.52%. The high price target for EW is $180.00 and the low price target for EW is $115.00. There are currently 2 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.942.942.842.80
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $147.40$145.40$129.8667$120.0526
Price Target Upside: 7.52% upside2.76% upside13.33% upside8.67% upside

Edwards Lifesciences (NYSE:EW) Consensus Price Target History

Price Target History for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE:EW) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2018SunTrust BanksReiterated RatingBuy$180.00MediumView Rating Details
3/20/2018CowenReiterated RatingBuy$165.00LowView Rating Details
2/2/2018GuggenheimReiterated RatingBuy$162.00LowView Rating Details
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform -> Market Outperform$135.00 -> $140.00HighView Rating Details
2/2/2018Stifel NicolausReiterated RatingBuy$155.00HighView Rating Details
2/2/2018BarclaysBoost Price TargetOverweight -> Overweight$135.00 -> $155.00HighView Rating Details
2/2/2018Morgan StanleyBoost Price TargetOverweight -> Overweight$130.00 -> $138.00HighView Rating Details
2/2/2018Canaccord GenuityReiterated RatingBuy -> Buy$140.00 -> $174.00HighView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$140.00HighView Rating Details
1/2/2018JPMorgan ChaseDowngradeOverweight -> NeutralMediumView Rating Details
12/8/2017BMO Capital MarketsReiterated RatingBuy$137.00LowView Rating Details
10/26/2017Deutsche BankLower Price TargetHold$122.00 -> $115.00N/AView Rating Details
9/1/2017Royal Bank of CanadaReiterated RatingBuy$130.00N/AView Rating Details
8/28/2017William BlairReiterated RatingOutperform -> OutperformLowView Rating Details
7/27/2017Bank of AmericaBoost Price TargetPositive -> Buy$140.00 -> $150.00HighView Rating Details
7/27/2017Jefferies GroupBoost Price TargetBuy$115.00 -> $132.00HighView Rating Details
5/16/2017Goldman SachsInitiated CoverageConviction-Buy$138.00LowView Rating Details
3/20/2017Northland SecuritiesSet Price TargetBuy$105.00LowView Rating Details
2/8/2017Credit Suisse GroupSet Price TargetBuy$120.00N/AView Rating Details
2/2/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/11/2016Wells FargoReiterated RatingBuyN/AView Rating Details
8/22/2016UBSReiterated RatingBuyN/AView Rating Details
7/27/2016CitigroupBoost Price TargetSell$86.00 -> $94.00N/AView Rating Details
6/21/2016Piper JaffrayReiterated RatingOverweight$123.00N/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Edwards Lifesciences (NYSE:EW) Earnings History and Estimates Chart

Earnings by Quarter for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE:EW) Earnings Estimates

2018 EPS Consensus Estimate: $4.47
2019 EPS Consensus Estimate: $5.11
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$0.98$1.12$1.08
Q2 20184$1.14$1.22$1.17
Q3 20184$1.05$1.13$1.08
Q4 20184$1.08$1.21$1.15
Q1 20192$1.23$1.30$1.27
Q2 20193$1.27$1.34$1.30
Q3 20193$1.19$1.22$1.21
Q4 20192$1.29$1.40$1.35

Edwards Lifesciences (NYSE EW) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018$1.04N/AView Earnings Details
2/1/2018Q4 2017$0.91$0.94$868.45 million$888.50 millionViewListenView Earnings Details
10/24/2017Q3 2017$0.86$0.84$833.85 million$821.50 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.88$1.08$839.16 million$842.00 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.82$0.94$776.51 million$883.50 millionViewN/AView Earnings Details
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
4/24/2012Q1 2012$0.24$0.27ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
10/25/2010Q3 2010$0.21$0.21ViewN/AView Earnings Details
7/21/2010Q2 2010$0.22$0.23ViewN/AView Earnings Details
4/20/2010Q1 2010$0.20$0.20ViewN/AView Earnings Details
2/4/2010Q4 2009$0.21$0.21ViewN/AView Earnings Details
10/21/2009Q3 2009$0.18$0.18ViewN/AView Earnings Details
7/20/2009Q2 2009$0.19$0.20ViewN/AView Earnings Details
4/27/2009Q1 2009$0.17$0.18ViewN/AView Earnings Details
2/3/2009Q4 2008$0.19$0.19ViewN/AView Earnings Details
10/21/2008Q3 2008$0.14$0.14ViewN/AView Earnings Details
7/22/2008Q2 2008$0.16$0.16ViewN/AView Earnings Details
4/22/2008Q1 2008$0.12$0.14ViewN/AView Earnings Details
2/5/2008Q4 2007$0.13$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Edwards Lifesciences (NYSE:EW) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Edwards Lifesciences (NYSE EW) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.84%
Institutional Ownership Percentage: 82.98%
Insider Trading History for Edwards Lifesciences (NYSE:EW)
Institutional Ownership by Quarter for Edwards Lifesciences (NYSE:EW)

Edwards Lifesciences (NYSE EW) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2018Larry L. WoodVPSell6,300$138.97$875,511.00View SEC Filing  
4/11/2018Jean-Luc M. LemercierVPSell5,633$139.42$785,352.86View SEC Filing  
4/4/2018Donald E. Bobo, Jr.VPSell4,000$134.78$539,120.00View SEC Filing  
4/4/2018Scott B UllemCFOSell25,000$137.17$3,429,250.0035,968View SEC Filing  
3/29/2018Donald E Bobo JrVPSell5,300$138.58$734,474.0024,908View SEC Filing  
3/28/2018Scott B UllemCFOSell25,000$137.33$3,433,250.0035,968View SEC Filing  
3/21/2018Michael A MussallemCEOSell32,800$139.74$4,583,472.0074,131View SEC Filing  
3/19/2018Huimin WangVPSell3,800$141.84$538,992.00View SEC Filing  
3/15/2018Larry L WoodVPSell6,300$141.49$891,387.00116,148View SEC Filing  
3/7/2018Jean-Luc M LemercierVPSell5,633$136.29$767,721.5744,298View SEC Filing  
2/20/2018Donald E Bobo JrVPSell5,300$134.70$713,910.0024,908View SEC Filing  
2/16/2018Larry L WoodVPSell6,300$134.27$845,901.00116,148View SEC Filing  
2/13/2018Michael A MussallemCEOSell32,800$126.69$4,155,432.0074,131View SEC Filing  
2/12/2018Donald E Bobo JrVPSell3,750$127.54$478,275.0019,608View SEC Filing  
2/9/2018William J Phd LinkDirectorSell12,000$122.24$1,466,880.0024,596View SEC Filing  
2/5/2018Robert W.A. SellersVPSell12,020$131.03$1,574,980.60View SEC Filing  
1/29/2018Donald E Bobo JrVPSell5,300$127.24$674,372.0024,908View SEC Filing  
1/16/2018Larry L WoodVPSell6,300$121.00$762,300.00116,148View SEC Filing  
1/4/2018Michael A. MussallemCEOSell32,800$114.97$3,771,016.00View SEC Filing  
12/28/2017Donald E. Bobo, Jr.VPSell5,300$114.08$604,624.00View SEC Filing  
12/28/2017Donald E. Bobo, Jr.VPSell5,300$114.08$604,624.00View SEC Filing  
12/19/2017Michael A. MussallemCEOSell32,800$114.82$3,766,096.00View SEC Filing  
12/15/2017Larry L. WoodVPSell18,960$114.58$2,172,436.80View SEC Filing  
11/29/2017Donald E. Bobo, Jr.VPSell5,300$116.45$617,185.00View SEC Filing  
11/20/2017Michael A. MussallemCEOSell32,900$106.86$3,515,694.00View SEC Filing  
11/15/2017Larry L. WoodVPSell18,960$104.76$1,986,249.60View SEC Filing  
11/9/2017Schack Wesley W VonDirectorSell1,000$104.15$104,150.002,622View SEC Filing  
10/30/2017Donald E. Bobo, Jr.VPSell5,300$101.12$535,936.00View SEC Filing  
10/30/2017Michael A. MussallemCEOSell32,900$100.93$3,320,597.00View SEC Filing  
10/16/2017Larry L WoodVPSell18,960$108.54$2,057,918.40View SEC Filing  
9/29/2017Donald E. Bobo, Jr.VPSell5,300$108.86$576,958.00View SEC Filing  
9/15/2017Larry L. WoodVPSell18,960$112.58$2,134,516.80View SEC Filing  
9/7/2017Michael A. MussallemCEOSell32,900$112.45$3,699,605.00View SEC Filing  
8/30/2017Larry L. WoodVPSell18,960$111.81$2,119,917.60View SEC Filing  
8/29/2017Donald E. Bobo, Jr.VPSell5,300$112.15$594,395.00View SEC Filing  
8/9/2017Michael A. MussallemCEOSell32,900$115.99$3,816,071.00View SEC Filing  
8/4/2017Donald E. Bobo, Jr.VPSell25,000$116.00$2,900,000.00View SEC Filing  
7/31/2017Catherine M. SzymanVPSell4,681$115.78$541,966.18View SEC Filing  
7/31/2017Michael A. MussallemCEOSell32,900$114.80$3,776,920.00View SEC Filing  
7/28/2017Donald E. Bobo, Jr.VPSell5,300$114.68$607,804.00View SEC Filing  
6/29/2017Donald E. Bobo, Jr.VPSell5,600$117.15$656,040.00View SEC Filing  
6/7/2017Michael A. MussallemCEOSell32,900$118.05$3,883,845.00View SEC Filing  
5/31/2017Patrick B. VerguetVPSell10,000$114.88$1,148,800.00View SEC Filing  
5/19/2017Dylan SidooDirectorBuy25,000$0.11$2,750.00
5/19/2017Patrick B. VerguetVPSell22,631$113.16$2,560,923.96View SEC Filing  
5/15/2017Patrick B. VerguetVPSell11,500$111.64$1,283,860.00View SEC Filing  
5/8/2017Donald E. Bobo, Jr.VPSell19,100$110.34$2,107,494.00View SEC Filing  
5/4/2017Donald E. Bobo, Jr.VPSell34,120$109.98$3,752,517.60View SEC Filing  
5/3/2017Michael A. MussallemCEOSell49,100$109.71$5,386,761.00View SEC Filing  
4/28/2017Michael A. MussallemCEOSell49,100$109.78$5,390,198.00View SEC Filing  
4/27/2017Bernard J. ZovighianVPSell18,050$109.21$1,971,240.50View SEC Filing  
4/5/2017Donald E. Bobo, Jr.VPSell13,720$93.58$1,283,917.60View SEC Filing  
3/30/2017Patrick B. VerguetVPSell24,000$93.90$2,253,600.00View SEC Filing  
3/6/2017Donald E. Bobo, Jr.VPSell13,720$90.01$1,234,937.20View SEC Filing  
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.002,524View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00127,341View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.0089,272View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66115,083View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.0062,796View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.001,941View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00129,944View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00129,944View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00129,944View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.0081,480View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.0068,256View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00115,107View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.0079,256View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.5081,480View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.0080,650View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.5081,299View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.0099,803View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.0067,649View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.0021,650View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.0021,650View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.0099,803View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.8033,824View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.0049,901View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.0013,158View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.0049,901View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.2034,174View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.2449,901View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.0049,901View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.0040,325View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.0034,174View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.0053,901View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.6043,838View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.0010,825View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.8034,174View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.0043,838View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00279,887View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.1150$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.1750$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.1350$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.1450$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.0020,604View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00263,850View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.0031,549View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.6977,199View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.0020,570View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00263,850View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.8077,199View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00263,850View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.0031,337View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.0048,681View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.5031,337View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00263,850View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00263,850View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.5031,337View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00263,850View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.0031,337View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00263,850View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.0031,337View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.0048,681View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Edwards Lifesciences (NYSE EW) News Headlines

Source:
DateHeadline
Edwards Lifesciences' (EW) THVT Likely to Drive Q1 EarningsEdwards Lifesciences' (EW) THVT Likely to Drive Q1 Earnings
finance.yahoo.com - April 20 at 4:34 PM
Edwards Lifesciences (EW) THVT Likely to Drive Q1 EarningsEdwards Lifesciences' (EW) THVT Likely to Drive Q1 Earnings
www.zacks.com - April 20 at 9:39 AM
Insider Selling: Edwards Lifesciences Corp (EW) VP Sells 6,300 Shares of StockInsider Selling: Edwards Lifesciences Corp (EW) VP Sells 6,300 Shares of Stock
www.americanbankingnews.com - April 18 at 10:10 PM
Bear of the Day: Barrick Gold (ABX)Bear of the Day: Barrick Gold (ABX)
finance.yahoo.com - April 18 at 9:44 AM
Edwards Lifesciences (EW) Upgraded by Zacks Investment Research to BuyEdwards Lifesciences (EW) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - April 17 at 5:25 PM
Edwards Lifesciences (EW) Downgraded by BidaskClub to BuyEdwards Lifesciences (EW) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - April 17 at 3:39 PM
Edwards Lifesciences (EW) Scheduled to Post Quarterly Earnings on TuesdayEdwards Lifesciences (EW) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 17 at 2:49 AM
Edwards Lifesciences Corp (EW) Given Consensus Rating of "Buy" by AnalystsEdwards Lifesciences Corp (EW) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - April 15 at 5:31 PM
Edwards Lifesciences (EW) Earns Buy Rating from Stifel NicolausEdwards Lifesciences (EW) Earns Buy Rating from Stifel Nicolaus
www.americanbankingnews.com - April 15 at 3:59 PM
Bank of America Boosts Edwards Lifesciences (EW) Price Target to $150.00Bank of America Boosts Edwards Lifesciences (EW) Price Target to $150.00
www.americanbankingnews.com - April 15 at 3:59 PM
Barclays Increases Edwards Lifesciences (EW) Price Target to $120.00Barclays Increases Edwards Lifesciences (EW) Price Target to $120.00
www.americanbankingnews.com - April 15 at 12:01 PM
Edwards Lifesciences (EW) vs. Mine Safety Appliances (MSA) Critical ComparisonEdwards Lifesciences (EW) vs. Mine Safety Appliances (MSA) Critical Comparison
www.americanbankingnews.com - April 13 at 9:45 AM
SunTrust Banks Equities Analysts Reduce Earnings Estimates for Edwards Lifesciences Corp (EW)SunTrust Banks Equities Analysts Reduce Earnings Estimates for Edwards Lifesciences Corp (EW)
www.americanbankingnews.com - April 13 at 9:29 AM
Q1 2018 EPS Estimates for Edwards Lifesciences Corp (EW) Lowered by Leerink SwannQ1 2018 EPS Estimates for Edwards Lifesciences Corp (EW) Lowered by Leerink Swann
www.americanbankingnews.com - April 13 at 8:43 AM
Edwards Lifesciences Corp (EW) VP Jean-Luc M. Lemercier Sells 5,633 SharesEdwards Lifesciences Corp (EW) VP Jean-Luc M. Lemercier Sells 5,633 Shares
www.americanbankingnews.com - April 12 at 10:10 PM
Edwards Lifesciences Corp (EW) to Post Q4 2018 Earnings of $1.16 Per Share, Leerink Swann ForecastsEdwards Lifesciences Corp (EW) to Post Q4 2018 Earnings of $1.16 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - April 12 at 7:46 AM
Brokers Set Expectations for Edwards Lifesciences Corps Q1 2018 Earnings (EW)Brokers Set Expectations for Edwards Lifesciences Corp's Q1 2018 Earnings (EW)
www.americanbankingnews.com - April 12 at 7:12 AM
Will Edwards' (EW) Growth in All Lines Drive Q1 Earnings?Will Edwards' (EW) Growth in All Lines Drive Q1 Earnings?
finance.yahoo.com - April 11 at 4:34 PM
Will Edwards (EW) Growth in All Lines Drive Q1 Earnings?Will Edwards' (EW) Growth in All Lines Drive Q1 Earnings?
www.zacks.com - April 11 at 10:05 AM
 Brokerages Anticipate Edwards Lifesciences Corp (EW) Will Announce Quarterly Sales of $931.39 Million Brokerages Anticipate Edwards Lifesciences Corp (EW) Will Announce Quarterly Sales of $931.39 Million
www.americanbankingnews.com - April 11 at 7:45 AM
Edwards Lifesciences (EW) Stock Rating Reaffirmed by SunTrust BanksEdwards Lifesciences (EW) Stock Rating Reaffirmed by SunTrust Banks
www.americanbankingnews.com - April 10 at 9:26 PM
Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018
finance.yahoo.com - April 10 at 4:31 PM
Abbott’s Stock Price Momentum Continues: What’s Ahead?Abbott’s Stock Price Momentum Continues: What’s Ahead?
finance.yahoo.com - April 10 at 9:43 AM
 Brokerages Expect Edwards Lifesciences Corp (EW) to Announce $1.10 Earnings Per Share Brokerages Expect Edwards Lifesciences Corp (EW) to Announce $1.10 Earnings Per Share
www.americanbankingnews.com - April 9 at 1:27 AM
Head-To-Head Analysis: Histogenics (HSGX) & Edwards Lifesciences (EW)Head-To-Head Analysis: Histogenics (HSGX) & Edwards Lifesciences (EW)
www.americanbankingnews.com - April 8 at 9:19 PM
Edwards Lifesciences Corp (EW) CFO Sells $3,429,250.00 in StockEdwards Lifesciences Corp (EW) CFO Sells $3,429,250.00 in Stock
www.americanbankingnews.com - April 5 at 10:21 PM
Edwards Lifesciences Corp (EW) VP Donald E. Bobo, Jr. Sells 4,000 SharesEdwards Lifesciences Corp (EW) VP Donald E. Bobo, Jr. Sells 4,000 Shares
www.americanbankingnews.com - April 5 at 10:21 PM
Edwards Lifesciences (EW) "Buy" Rating Reaffirmed at Canaccord GenuityEdwards Lifesciences' (EW) "Buy" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - April 5 at 2:58 PM
Edwards Lifesciences Gets CE Mark Approval for Its Centera ValveEdwards Lifesciences Gets CE Mark Approval for Its Centera Valve
finance.yahoo.com - April 5 at 9:03 AM
Edwards Lifesciences Delays European Launch of Sapien 3 UltraEdwards Lifesciences Delays European Launch of Sapien 3 Ultra
finance.yahoo.com - April 5 at 9:03 AM
Edwards Lifesciences (EW) Price Target Cut to $120.00 by Analysts at Morgan StanleyEdwards Lifesciences (EW) Price Target Cut to $120.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - April 4 at 7:30 PM
Edwards Lifesciences (EW) Given New $115.00 Price Target at Deutsche BankEdwards Lifesciences (EW) Given New $115.00 Price Target at Deutsche Bank
www.americanbankingnews.com - April 4 at 7:30 PM
Edwards Lifesciences (EW) Downgraded by Zacks Investment Research to HoldEdwards Lifesciences (EW) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 4 at 12:51 PM
Walgreens Boots' Retail Business Solid Amid Several ConcernsWalgreens Boots' Retail Business Solid Amid Several Concerns
finance.yahoo.com - April 2 at 4:36 PM
Has Edwards Lifesciences Corporation (NYSE:EW) Improved Earnings Growth In Recent Times?Has Edwards Lifesciences Corporation (NYSE:EW) Improved Earnings Growth In Recent Times?
finance.yahoo.com - March 31 at 9:16 AM
Edwards Lifesciences (EW) Coverage Initiated by Analysts at Evercore ISIEdwards Lifesciences (EW) Coverage Initiated by Analysts at Evercore ISI
www.americanbankingnews.com - March 30 at 11:40 PM
Edwards Lifesciences Corp (EW) CFO Scott B. Ullem Sells 25,000 SharesEdwards Lifesciences Corp (EW) CFO Scott B. Ullem Sells 25,000 Shares
www.americanbankingnews.com - March 30 at 10:16 PM
Edwards Lifesciences Corp (EW) VP Sells $734,474.00 in StockEdwards Lifesciences Corp (EW) VP Sells $734,474.00 in Stock
www.americanbankingnews.com - March 30 at 10:14 PM
Edwards Lifesciences (EW) Upgraded at BarclaysEdwards Lifesciences (EW) Upgraded at Barclays
www.americanbankingnews.com - March 30 at 4:32 PM
Walgreens Boots (WBA) Beats on Earnings in Q2, Lifts ViewWalgreens Boots (WBA) Beats on Earnings in Q2, Lifts View
finance.yahoo.com - March 28 at 4:29 PM
DexCom (DXCM) Gets FDA Approval for G6 CGM Monitoring SystemDexCom (DXCM) Gets FDA Approval for G6 CGM Monitoring System
finance.yahoo.com - March 28 at 4:29 PM
Boston Scientific prevails over Edwards in UK patent disputeBoston Scientific prevails over Edwards in UK patent dispute
seekingalpha.com - March 28 at 9:25 AM
Zimmer Biomet Holdings, Inc. (ZBH) Ex-Dividend Date Scheduled for March 28, 2018Zimmer Biomet Holdings, Inc. (ZBH) Ex-Dividend Date Scheduled for March 28, 2018
www.nasdaq.com - March 27 at 4:36 PM
DMC Global Inc. (BOOM) Ex-Dividend Date Scheduled for March 28, 2018DMC Global Inc. (BOOM) Ex-Dividend Date Scheduled for March 28, 2018
www.nasdaq.com - March 27 at 4:36 PM
Edwards Lifesciences prevails in challenge to Boston Sci valve patentEdwards Lifesciences prevails in challenge to Boston Sci valve patent
seekingalpha.com - March 26 at 10:22 AM
3 Reasons Why You Should Invest in Edwards Lifesciences Now3 Reasons Why You Should Invest in Edwards Lifesciences Now
www.zacks.com - March 26 at 10:22 AM
Edwards Lifesciences (EW) "Buy" Rating Reaffirmed at CowenEdwards Lifesciences' (EW) "Buy" Rating Reaffirmed at Cowen
www.americanbankingnews.com - March 25 at 9:48 PM
$931.39 Million in Sales Expected for Edwards Lifesciences Corp (EW) This Quarter$931.39 Million in Sales Expected for Edwards Lifesciences Corp (EW) This Quarter
www.americanbankingnews.com - March 25 at 9:59 AM
Michael A. Mussallem Sells 32,800 Shares of Edwards Lifesciences Corp (EW) StockMichael A. Mussallem Sells 32,800 Shares of Edwards Lifesciences Corp (EW) Stock
www.americanbankingnews.com - March 23 at 10:14 PM
Edwards (EW) Completes Enrollment for PARTNER 3 Sub-StudyEdwards (EW) Completes Enrollment for PARTNER 3 Sub-Study
finance.yahoo.com - March 23 at 6:18 PM

SEC Filings

Edwards Lifesciences (NYSE:EW) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Edwards Lifesciences (NYSE:EW) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Edwards Lifesciences (NYSE EW) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.